s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Wednesday, September 23, 2020
Accession number
0000950123-20-009900
Documents
filename1.htm
DRS
On sec.gov
Filing index
All files
Complete submission text
SGML header